142
Views
2
CrossRef citations to date
0
Altmetric
Case Reports

Invasive Fungal Sinusitis with Ophthalmological Complications: Case Series and Review of the Literature

ORCID Icon, , , &
Pages 193-204 | Received 29 Jan 2020, Accepted 27 May 2020, Published online: 21 Jul 2020

References

  • Krennmair G, Lenglinger F. Maxillary sinus aspergillosis: diagnosis and differentiation of the pathogenesis based on computed tomography densitometry of sinus concretions. J Oral Maxillofac Surg. 1995;53(6):657–663. doi:10.1016/0278-2391(95)90164-7.
  • Rankin NE. Disseminated aspergillosis and moniliasis associated with agranulocytosis and antibiotic therapy. Br Med J. 1953;1(4816):918–919. doi:10.1136/bmj.1.4816.918.
  • Sivak-Callcott JA, Livesley N, Nugent RA, Rasmussen SL, Saeed P, Rootman J. Localised invasive sino-orbital aspergillosis: characteristic features. Br J Ophthalmol. 2004;88(5):681–687. doi:10.1136/bjo.2003.021725.
  • Marple BF, Gibbs SR, Newcomer MT, Mabry RL. Allergic fungal sinusitis-induced visual loss. Am J Rhinol. 1999;13(3):191–195. doi:10.2500/105065899781389740.
  • Denning DW. Invasive aspergillosis. Clin Infect Dis. 1998;26:781–805. doi:10.1086/513943.
  • Denning DW. Therapeutic outcome in invasive aspergillosis. Clin Infect Dis. 1996;23(3):608–615. doi:10.1093/clinids/23.3.608.
  • Bellazreg F, Hattab Z, Meksi S, et al. Outcome of mucormycosis after treatment: report of five cases. New Microbes New Infect. 2015;6:49–52. doi:10.1016/j.nmni.2014.12.002.
  • Nithyanandam S, Jacob MS, Battu RR, Thomas RK, Correa MA, D’Souza O. Rhino-orbito-cerebral mucormycosis. A retrospective analysis of clinical features and treatment outcomes. Indian J Ophthalmol. 2003;51:231–236.
  • Lin S, Schranz J, Teutsch SM. Aspergillosis case-fatality rate: systematic review of the literature. 2001;60612. Clin Infect Dis. 2001 Feb 1;32(3):358–366. Epub 2001 Jan 26. doi:10.1086/318483.
  • Katragkou A, Walsh TJ, Roilides E. Why is mucormycosis more difficult to cure than more common mycoses? Clin Microbiol Infect. 2014;20(s6):74–81. doi:10.1111/1469-0691.12466.
  • Trief D, Gray ST, Jakobiec FA, et al. Invasive fungal disease of the sinus and orbit: a comparison between mucormycosis and Aspergillus. Br J Ophthalmol. 2016;100(2):184–188.doi:10.1136/bjophthalmol-2015-306945.
  • Hurst RW, Judkins A, Bolger W, Chu A, Loevner LA. Mycotic aneurysm and cerebral infarction resulting from fungal sinusitis: imaging and pathologic correlation. Am J Neuroradiol. 2001;22:858–863.
  • Koc Z, Koc F, Yerdelen D, Ozdogu H. Rhino-orbital-cerebral mucormycosis with different cerebral involvements: infarct, hemorrhage, and ophthalmoplegia. Int J Neurosci. 2007;117(12):1677–1690. doi:10.1080/00207450601050238.
  • Rallis G, Gkinis G, Dais P, Stathopoulos P. Visual loss due to paranasal sinus invasive aspergillosis in a diabetic patient. Ann Maxillofac Surg. 2014;4(2):247–250. doi:10.4103/2231-0746.147169.
  • Patterson TF, Thompson GR, Denning DW, et al. Executive summary: practice guidelines for the diagnosis and management of aspergillosis: 2016 update by the infectious diseases society of America. Clin Infect Dis. 2016;63(4):433–442.doi:10.1093/cid/ciw444.
  • Latge JP. The pathobiology of Aspergillus fumigatus. Trends Microbiol. 2001;9(8):382–389. doi:10.1016/S0966-842X(01)02104-7.
  • Sarkar P, Price C, Fish M, et al. Skull base aspergillosis in an immunocompetent elderly man with early response to steroid. BMJ Case Rep CP. 2018;11:e226998. doi:10.1136/bcr-2018-226998.
  • Wang JK, Lin S-Y, Lai P-C, Jou J-R. Compressive optic neuropathy secondary to sphenoid sinus aspergillosis. Neuro-Ophthalmology. 2005;29(2):77–80. doi:10.1080/01658100590933460.
  • McLean FM, Ginsberg LE, Stanton CA. Perineural spread of rhinocerebral mucormycosis. Am J Neuroradiol. 1996;17:114–116.
  • deShazo RD, O’Brien M, Chapin K, Soto-Aguilar M, Gardner L, Swain R. A new classification and diagnostic criteria for invasive fungal sinusitis. JAMA Otolaryngol Neck Surg. 1997;123(11):1181–1188. doi:10.1001/archotol.1997.01900110031005.
  • Leyngold I, Olivi A, Ishii M, et al. Acute chiasmal abscess resulting from perineural extension of invasive sino-orbital aspergillosis in an immunocompetent patient. World Neurosurg. 2014;81(1):203.e1-203.e2036.doi:10.1016/j.wneu.2013.08.018.
  • Thurtell MJ, Chiu ALS, Goold LA, et al. Neuro-ophthalmology of invasive fungal sinusitis: 14 consecutive patients and a review of the literature. Clin Exp Ophthalmol. 2013;41(6):567–576.doi:10.1111/ceo.12055.
  • Brandwein M. Histopathology of sinonasal fungal disease. Otolaryngol Clin North Am. 1993;26:949–981.
  • Montone KT. Pathology of fungal rhinosinusitis: a review. Head Neck Pathol. 2016;10(1):40–46. doi:10.1007/s12105-016-0690-0.
  • Ghabrial R, Ananda A, van Hal SJ, et al. Invasive fungal sinusitis presenting as acute posterior ischemic optic neuropathy. Neuro-Ophthalmology. 2018;42(4):209–214.doi:10.1080/01658107.2017.1392581.
  • Tissot F, Agrawal S, Pagano L, et al. ECIL-6 guidelines for the treatment of invasive candidiasis, aspergillosis and mucormycosis in leukemia and hematopoietic stem cell transplant patients. Haematologica. 2017;102(3):433–444.doi:10.3324/haematol.2016.152900.
  • Chang Y-M, Chang Y-H, Chien K-H, et al. Orbital apex syndrome secondary to aspergilloma masquerading as a paranasal sinus tumor: a case report and literature review. Medicine (Baltimore). 2018;97(30):e11650.doi:10.1097/MD.0000000000011650.
  • Cho SH, Jin BJ, Lee YS, Paik SS, Ko MK, Yi H-J. Orbital apex syndrome in a patient with sphenoid fungal balls. Clin Exp Otorhinolaryngol. 2009;2(1):52–54. doi:10.3342/ceo.2009.2.1.52.
  • Kontoyiannis DP, Bodey GP. Invasive aspergillosis in 2002: an update. Eur J Clin Microbiol Infect Dis. 2002;21(3):161–172. doi:10.1007/s10096-002-0699-z.
  • Levin LA, Avery R, Shore JW, Woog JJ, Sullivan Baker A. The spectrum of orbital aspergillosis: a clinicopathological review. Surv Ophthalmol. 1996;41(2):142–154. doi:10.1016/S0039-6257(96)80004-X.
  • Yoshida K, Shirata A, Sato T, Kishida Y, Saito K, Yamane K. A case of orbital apex syndrome due to aspergillus infection that avoided loss of visual acuity by optic canal decompression. Rinsho Shinkeigaku. 2016;56(1):1–6. doi:10.5692/clinicalneurol.cn-000741.
  • Patterson TF, Kirkpatrick WR, White M, et al. Invasive aspergillosis. Disease spectrum, treatment practices, and outcomes. I3 Aspergillus Study Group. Medicine (Baltimore). 2000;79(4):250–260.doi:10.1097/00005792-200007000-00006.
  • Jenks JD, Salzer HJ, Prattes J, Krause R, Buchheidt D, Hoenigl M. Spotlight on isavuconazole in the treatment of invasive aspergillosis and mucormycosis: design, development, and place in therapy. Drug Des Devel Ther. 2018;12:1033–1044. doi:10.2147/DDDT.S145545.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.